Antiphospholipid antibodies and the antiphospholipid syndrome: An update on treatment and pathogenic mechanisms

Silvia S. Pierangeli, Pojen P. Chen, Emilio Gonzalez

Research output: Contribution to journalArticle

71 Scopus citations

Abstract

PURPOSE OF REVIEW: The antiphospholipid syndrome is a disorder of recurrent thrombosis, pregnancy loss and thrombocytopenia associated with the presence of antiphospholipid antibodies and persistently positive anticardiolipin or lupus anticoagulant positive tests. Since its recognition in the 1980s, growing interest in the field, not only with respect to diagnosis and treatment, but also regarding the pathogenesis of antiphospholipid antibodies, has emerged. RECENT FINDINGS: First, this review addresses the recently updated classification criteria for diagnosis and treatment of the antiphospholipid syndrome. A discussion on the newly described potential beneficial roles of hydroxychloroquine and the statins for the treatment of antiphospholipid syndrome-associated clinical manifestations is included. Importantly, this article analyzes recent data that examine the molecular and intracellular events that antiphospholipid antibodies trigger in target cells, as well as new findings in the identification of the receptors for these antibodies on the membrane of those cells. A separate section discusses novel pathogenic mechanisms of antiphospholipid antibodies, including the activation of complement and their interaction with homologous catalytic domains of several serine proteases of the coagulation system. SUMMARY: Understanding the molecular interactions and the intracellular signaling that antiphospholipid antibodies trigger, new therapeutic and targeted strategies to ameliorate clinical manifestations in patients with antiphospholipid syndrome may be established.

Original languageEnglish (US)
Pages (from-to)366-375
Number of pages10
JournalCurrent Opinion in Hematology
Volume13
Issue number5
DOIs
StatePublished - Sep 2006

    Fingerprint

Keywords

  • Antiphospholipid antibodies
  • Complement activation
  • Intracellular signalling
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this